Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

amino acid PET

  • An External, Independent Validation of an <em>O</em>-(2-[<sup>18</sup>F]Fluoroethyl)-<span class="sc">l</span>-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
    You have access
    An External, Independent Validation of an O-(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
    Nathaniel Barry, Jake Kendrick, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Roslyn J. Francis, Nicholas Bucknell, Eng-Siew Koh, Andrew M. Scott, Martin A. Ebert, Robin Gutsche, Keith George Ciantar, Norbert Galldiks, Karl-Josef Langen and Philipp Lohmann
    Journal of Nuclear Medicine June 1, 2025, 66 (6) 948-953; DOI: https://doi.org/10.2967/jnumed.124.268925
  • Borderline Findings in <em>O</em>-(2-[<sup>18</sup>F]-Fluoroethyl)-<span class="sc">l</span>-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
    You have access
    Borderline Findings in O-(2-[18F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
    Karl-Josef Langen, Gabriele Stoffels, Christian P. Filss, Martin Kocher, Christoph Lerche, Michael Sabel, Marion Rapp, Hosai Noltemeier, Jan-Michael Werner, Garry Ceccon, Michael M. Wollring, Jurij Rosen, Joachim P. Steinbach, Elke Hattingen, Martin R. Weinzierl, Michael Stoffel, Hans Clusmann, N. Jon Shah, Felix M. Mottaghy, Norbert Galldiks and Philipp Lohmann
    Journal of Nuclear Medicine February 1, 2025, 66 (2) 187-193; DOI: https://doi.org/10.2967/jnumed.124.268768
  • MRI and <sup>18</sup>F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis
    You have access
    MRI and 18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis
    Jurij Rosen, Jan-Michael Werner, Garry S. Ceccon, Elena K. Rosen, Michael M. Wollring, Isabelle Stetter, Philipp Lohmann, Felix M. Mottaghy, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
    Journal of Nuclear Medicine June 1, 2024, 65 (6) 838-844; DOI: https://doi.org/10.2967/jnumed.123.266687
  • Hybrid <sup>18</sup>F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
    Open Access
    Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
    Nathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins and Michael C. Veronesi
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.122.265149
  • Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
    You have access
    Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
    Jurij Rosen, Garry Ceccon, Elena K. Bauer, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schäfer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1677-1682; DOI: https://doi.org/10.2967/jnumed.122.263790
  • You have access
    Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
    Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 918-925; DOI: https://doi.org/10.2967/jnumed.120.254243
  • You have access
    Flare Phenomenon in O-(2-18F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas
    Christian P. Filss, Ann K. Schmitz, Gabriele Stoffels, Carina Stegmayr, Philipp Lohmann, Jan Michael Werner, Michael Sabel, Marion Rapp, Roland Goldbrunner, Bernd Neumaier, Felix M. Mottaghy, N. Jon Shah, Gereon R. Fink, Norbert Galldiks and Karl-Josef Langen
    Journal of Nuclear Medicine September 1, 2020, 61 (9) 1294-1299; DOI: https://doi.org/10.2967/jnumed.119.238568
  • You have access
    Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
    László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
    Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267
SNMMI

© 2025 SNMMI

Powered by HighWire